Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

KERYX BIOPHARMACEUTICALS INC (KERX)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues   [+]60.632.013.710.87.028.65.00.0
            Revenue growth  89.6%133.8%26.4%54.6%-75.5%471.6% -100.0%
Cost of goods sold   [+]25.040.76.60.50.00.0-65.4-40.0
Gross profit  35.6-8.77.010.37.028.670.440.0
            Gross margin  58.7%-27.2%51.4%95.4%100.0%100.0%1408.1% 
Selling, general and administrative   [+]99.684.681.470.119.37.012.211.3
Research and development  37.729.536.751.534.720.053.228.7
Other operating expenses       27.133.721.2
EBITDA   [+]-100.8-121.8-110.5-110.9-47.0-25.5-28.7-21.2
            EBITDA margin  -166.1%-380.7%-807.5%-1024.7%-671.8%-89.4%-574.0% 
Depreciation and amortization  0.91.00.60.30.10.00.00.1
EBIT   [+]-101.7-122.8-111.1-111.2-47.1-25.6-28.7-21.2
            EBIT margin  -167.7%-383.8%-811.9%-1027.5%-672.6%-89.5%-575.0% 
Non-recurring items       1.5  
Interest expense, net   [+]-0.7-0.7-0.5-0.3-0.2-0.1-0.2-0.1
Other income (expense), net   [+]0.3-4.7-12.50.10.21.70.20.6
Pre-tax income  -163.7-161.0-123.1-110.8-46.7-25.4-28.4-20.5
Income taxes  -0.20.10.10.70.0-2.6-0.2-7.2
            Tax rate  0.1%   0.0%10.4%0.9%35.0%
Earnings from continuing ops  -163.4-161.1-123.1-111.5-46.7-22.7-28.4-20.5
Earnings from discontinued ops        0.20.1
Net income  -163.4-161.1-123.1-111.5-46.7-22.7-28.1-20.3
            Net margin  -269.5%-503.7%-900.2%-1030.2%-667.6%-79.5%-562.5% 
   
Basic EPS   [+]($1.43)($1.52)($1.19)($1.23)($0.58)($0.32)($0.42)($0.35)
Diluted EPS   [+]($1.43)($1.52)($1.19)($1.23)($0.58)($0.32)($0.42)($0.35)
   
Shares outstanding (basic)   [+]114.5105.8103.991.081.071.667.459.0
Shares outstanding (diluted)   [+]114.5105.8103.991.081.071.667.459.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy